Watch Ticker

Autolus Therapeutics plc American Depositary Share

Go to Autolus Therapeutics plc American Depositary Share Website

$2.37

0.00 (0.00%)

Live

Previous Close

$2.37

Day Range

$0 - $0

Previous Day Range

$2.34 - $2.42

Market Cap

$633.4 million USD

Day Vol.

Previous Day Vol.

1.8 million

Currency

USD

Primary Exchange

Nasdaq

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUT...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Autolus Therapeutics - Autolus Therapeutics’ CAR T Therapy AUCATZYL® (Obecabtagene Autoleucel) Granted European Marketing Authorization for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)

Autolus Therapeutics received European marketing authorization for AUCATZYL®, a CAR T cell therapy treating adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia, based on successful FELIX clinical trial results.

Related tickers: AUTL.

Read Full Article

N/A - Autolus Therapeutics to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025

Autolus Therapeutics, an early commercial stage biopharmaceutical company, will release its first quarter 2025 financial results and host a conference call on May 8, 2025 to discuss the company's financial results and provide a general business update.

Related tickers: AUTL.

Read Full Article

Trending Tickers

Please sign in to view